Metabolites to parent 3-MeO-PCP ratio in human urine collected in two fatal cases-Reference-Cited by-同舟云学术

Metabolites to parent 3-MeO-PCP ratio in human urine collected in two fatal cases

Published:2018-11-22 Issue:4 Volume:43 Page:321-324
ISSN:0146-4760
Container-title:Journal of Analytical Toxicology
language:en
Short-container-title:

Author:

Ameline Alice¹²,Greney Hugues²,Monassier Laurent²,Raul Jean-sébastien¹²,Kintz Pascal¹²³

Affiliation:

1. Institut de Médecine Légale, Université de Strasbourg, 11 rue Humann, Strasbourg, France

2. Laboratoire de Pharmacologie et Toxicologie NeuroCardiovasculaire, EA 7296,, 11 rue Humann, Strasbourg, France

3. X-Pertise Consulting, 84 route de Saverne, Oberhausbergen, France

Publisher

Oxford University Press (OUP)

Subject

Chemical Health and Safety,Health, Toxicology and Mutagenesis,Toxicology,Environmental Chemistry,Analytical Chemistry

Link

http://academic.oup.com/jat/article-pdf/43/4/321/28359218/bky097.pdf

Reference9 articles.

1. Conformational determination of phencyclidine derivatives in view of structure-activity correlation;Geneste;European Journal of Medicinal Chemistry,1979

2. The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor;Roth;Plos One,2013

3. From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs;Morris;Drug Testing and Analysis,2014

4. Murdered while under the influence of 3-MeO-PCP;Kintz;International Journal of Legal Medicine,2018

5. New psychoactive substances 3-methoxyphencyclidine (3-MeO-PCP) and 3-methoxyrolicyclidine (3-MeO-PCPy): metabolic fate elucidated with rat urine and human liver oreoarations and their detectability in urine by GC-MS, “LC-(High Resolution)-MSn” and “LC-(High Resolution)-MS/MS”;Michely;Current Neuropharmacology,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolism of four novel structural analogs of ketamine, 2‐FXE [2‐(ethylamino)‐2‐(2‐fluorophenyl) cyclohexan‐1‐one], 2‐MDCK [2‐(methylamino)‐2‐(o‐tolyl) cyclohexan‐1‐one], 3‐DMXE [2‐(ethylamino)‐2‐(m‐tolyl) cyclohexan‐1‐one], and 2‐DMXE [2‐(ethylamino)‐2‐(o‐tolyl) cyclohexan‐1‐one], in human liver microsomes based on ultra‐performance liquid chromatography–high‐resolution tandem mass spectrometry;Biomedical Chromatography;2023-11-22

2. Characterization of 3-Hydroxyeticyclidine (3-HO-PCE) Metabolism in Human Liver Microsomes and Biological Samples Using High-Resolution Mass Spectrometry;Metabolites;2023-03-16

3. Arylcyclohexylamine Derivatives: Pharmacokinetic, Pharmacodynamic, Clinical and Forensic Aspects;International Journal of Molecular Sciences;2022-12-08

4. Use of innovative, cross-disciplinary in vitro, in silico and in vivo approaches to characterize the metabolism of chloro-alpha-pyrrolidinovalerophenone (4-Cl-PVP);Archives of Toxicology;2022-12-05

5. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review;Journal of Analytical Toxicology;2022-04-21